Prenumeration
Following a successful exhibition at the Supply Side West trade show in Las Vegas, US, last week, Eevia Health (”Eevia” or ”the company”) received an order for the elderberry extract Feno-Sambucus™, corresponding to SEK 34.4 million in order value. The order is a new contractual volume section related to a five-year sales agreement with a US brand owner.
About Analyst Group: One of Sweden's leading equity analysis houses with a focus on small and medium-sized listed companies.
Read more about Analyst Group
This is a press release from Analyst Group regarding the publication of comments on Eeevia Health. Readers may assume that Analyst Group has received compensation for making the commentary. The Company has not been given an opportunity to influence the parts where Analyst Group has had opinions about the Company, future valuation or anything else that could be considered a subjective assessment.